Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement with BrainStorm Therapeutics; Initial Parkinson's Disease Data Readout Targeted for First Half of 2027

PartnershipPositive

AI Analysis

Summary

Lunai Bioworks and BrainStorm Therapeutics have signed a definitive collaboration agreement for Parkinson's Disease research with initial data readout expected in the first half of 2027.

Outcome Details

Definitive collaboration agreement signed with data readout targeted for H1 2027

Importance:6/10

Sentiment:

0.50

partnershipcollaborationParkinson's Diseasedata readout

Related Companies

$LNAI

Read the original article

Published by yahoo_finance on August 4, 2026 7:28 PM

Read Original